Your email has been successfully added to our mailing list.

×
0.0014634146341464 0.0014634146341464 0.0014634146341464 0.0014634146341464 0.0014634146341464 0.0014634146341464 0.0014634146341464 0.0014634146341464
Stock impact report

ERYTECH Provides Business Update and Reports Financial Results for Full Year 2017

Erytech Pharma S.A. - American Depositary Shares (ERYP) 
US:NASDAQ Investor Relations: investors.erytech.com
Company Research Source: Business Wire
Conference call and webcast on Tuesday, March 13th at 1:30 pm CET/8:30 am EDT Reported positive data from Phase 2b clinical trial of eryaspase in second-line metastatic pancreatic cancer Resubmitted the European Marketing Authorization Application (MAA) for eryaspase (GRASPA®) in relapsed and refractory acute lymphoblastic leukemia (ALL) Raised approximately €194 million ($226 million) in capital through a private placement in April 2017 and a global public offering in connection with Nasdaq listing in November 2017 Cash position of €185.5 million ($223 million) at year-end LYON, France--(BUSINESS WIRE)-- Regulatory News: ERYTECH Pharma (Euronext: ERYP - Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, tod Show less Read more
Impact Snapshot
Event Time:
ERYP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ERYP alerts
Opt-in for
ERYP alerts

from News Quantified
Opt-in for
ERYP alerts

from News Quantified